# Vaxine Pty Ltd.

Canonical: https://abierto.us/vendors/vaxine-pty-ltd-z9auc2snx5a4

- UEI: Z9AUC2SNX5A4
- CAGE: Z0ED5
- Location: Bedford Park, AUS
- Awards in window: 2 (3 transactions), -$535,698 obligated, February 11, 2025 to June 15, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, -$535,698

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$535,698

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75N93018C00044 (definitive contract): -$0, National Institutes of Health Niaid. Adjuvant Development Program. https://www.usaspending.gov/award/CONT_AWD_75N93018C00044_7529_-NONE-_-NONE-/
- 75N93018C00024 (definitive contract): -$535,698, National Institutes of Health Niaid. To Advance the Novel H7-Advax Pandemic Vaccine Candidates Through to Phase 1 Clinical Trials Through Delivery to the Government Of: Preliminary Data Regarding Adjuvant for Formulations (Base Requirement/Clin 001); Manufactured Product (Release) for S. https://www.usaspending.gov/award/CONT_AWD_75N93018C00024_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/vaxine-pty-ltd-z9auc2snx5a4.